Physician profile
Judah P Guy
NPI 1225301245
$5,852.20
in general payments reported to CMS, 2019-2025
36 companies · $1,406 in 2025
The $1,406 reported for 2025 was more than what 89% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $53.06 · 2021: $607 · 2022: $468 · 2023: $1,435 · 2024: $1,758 · 2025: $1,406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,567 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,566.93 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,105.51 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $935.96 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $420.56 | 2024-2025 | Gemtesa |
| Novartis Pharmaceuticals Corporation | $418.00 | 2021-2025 | |
| Pfizer INC. | $357.83 | 2021-2025 | |
| Phathom Pharmaceuticals, INC. | $235.10 | 2023-2024 | Voquezna |
| Boehringer Ingelheim Pharmaceuticals, INC. | $233.16 | 2021-2025 | Jardiance, Tradjenta, Ofev |
| Astrazeneca Pharmaceuticals LP | $227.12 | 2020-2025 | Farxiga, Breztri, Wainua |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $218.30 | 2022-2023 | Trulance |
| Idorsia Pharmaceuticals US INC | $204.61 | 2022-2024 | Quviviq |
| Amgen INC. | $175.36 | 2023-2025 | Otezla, Repatha, Repatha |
| Lilly USA, LLC | $164.63 | 2021-2025 | Zepbound, Jardiance, Mounjaro |
| Gilead Sciences, INC. | $125.00 | 2019 | |
| Daiichi Sankyo INC. | $123.65 | 2022-2023 | Injectafer |
| Inspire Medical Systems, INC. | $99.69 | 2025 | Inspire |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judah Guy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.